Disarming Deadly Viruses: High Throughput Protease Screening using Massive Peptide Libraries

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/301267

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Viral diseases affect millions of people worldwide with mortality rates as high as 50%. Viral enzymes help liberate proteins essential for viral replication. The rapid identification of the activity and specificity of these viral enzymes is important to combat outbreaks of viral disease and has become possible through biomedical device technology developed by the industry partner. With just 17 new drugs approved by the FDA in 2002, the proposed program has the potential to deliver new drugs quickly and efficiently, and this will be of benefit to viral disease sufferers worldwide.

Funded Activity Details

Start Date: 01-01-2004

End Date: 01-01-2008

Funding Scheme: Early Career Fellowships

Funding Amount: $405,625.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Biotechnology Not Elsewhere Classified

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

Infectious diseases | Medicianl chemistry | Protease | Protease Inhibitors | Screening

Related Links